Natuzzi ADSs on NYSE suspended as exchange starts delisting process
Reuters2026/08/27 19:44- NYSE suspended trading in Natuzzi American Depositary Shares, ticker NTZ, on Aug. 26.
- NYSE began delisting proceedings over failure to meet Section 802.01B’s US$ 15 million average global market-cap threshold for ADSs.
- Natuzzi is reviewing the determination, weighing an appeal under NYSE procedures.
- Without a successful appeal, delisting would take effect 10 days after NYSE files Form 25 with the SEC.
- ADSs are expected to move to the over-the-counter market if delisted; Natuzzi does not plan to terminate the ADS facility.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
